Vitrolife: A Time-lapse in Slow Motion
Research Update
2018-07-18
07:30
Following the Q2 result, we have updated our model. We lower our expectations for sales growth in the near-term and lower our fair value (base case) to SEK 110 (120) per share.
AN
Arvid Necander
Disclosures and disclaimers